Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Comparison of Cost-Effectiveness of Anticoagulation with Dabigatran, Rivaroxaban and Apixaban in Patients with Non-Valvular Atrial Fibrillation Across Countries

Martin Krejczy, Job Harenberg, Prof., Dr., Svetlana Marx, Konrad Obermann, Prof., Dr., Martin Wehling, Prof., Dr.

Blood (2012) 120 (21): 1164.

https://doi.org/10.1182/blood.V120.21.1164.1164

Published: 2012

Journal Articles

Cluster Analysis Followed by Network Meta-Analysis to Compare Efficacy and Safety of Dabigatran, Rivaroxaban and Apixaban After Elective Total Knee and Hip Replacement Surgery

Job Harenberg, Prof., Dr., Svetlana Marx, Shabnam Zolfaghari, Christel Weiss, Dr., Martin Wehling, Prof., Dr., Astrid Schulze, Dr., Ola E Dahl, MD

Blood (2012) 120 (21): 3409.

https://doi.org/10.1182/blood.V120.21.3409.3409

Published: 2012

Journal Articles

Indirect Comparisons of the New Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation

Shabnam Zolfaghari, Jr., M.Sc., Job Harenberg, Prof., Dr., Svetlana Marx, Martin Wehling, Prof., Dr.

Blood (2012) 120 (21): 4363.

https://doi.org/10.1182/blood.V120.21.4363.4363

Published: 2012

Journal Articles

Bleeding Intensity Following Tooth Extraction Is Moderated by Anxiety Independently of Treatment with anticoagulants– Development of an Internet Based Questionnaire Across Countries

Shabnam Zolfaghari, Svetlana Marx, Jeelka Fischer, Parastoo Hassani, Marinella Damian, Dr., Lutz Frölich, Prof., Dr., Job Harenberg, Prof., Dr.

Blood (2012) 120 (21): 4364.

https://doi.org/10.1182/blood.V120.21.4364.4364

Published: 2012

Journal Articles

The Point of Care Monitor Coagucheck-XS Displays the Lowest Coefficient of Variation for Determination of Rivaroxaban Compared to Prothrombin Time and Chromogenic Assays,

Job Harenberg, Prof., Dr., Christina Giese, Svetlana Marx, Dipl., Math.

Blood (2011) 118 (21): 3353.

https://doi.org/10.1182/blood.V118.21.3353.3353

Published: 2011

Journal Articles

Which Patients Would Be Willing to Change Anticoagulation From Vitamin-K Antagonists to a New Oral Anticoagulant?

Job Harenberg, Svetlana Marx, Nadja Abou-Ayash, Christophe Kremer, Vera Hoeing, Katrin Schirk, Christel Weiss, Lutz Froelich

Blood (2011) 118 (21): 4318.

https://doi.org/10.1182/blood.V118.21.4318.4318

Published: 2011

Journal Articles

Determination of the International Sensitivity Index for Rivaroxaban Using the WHO RBT/90 Thromboplastin as a Calibrant for Other Thromboplastin Reagents.

Job Harenberg, Prof., Dr., Christina Giese, Svetlana Marx, Dipl., Math., Roland Kraemer, Prof., Dr.

Blood (2010) 116 (21): 1089.

https://doi.org/10.1182/blood.V116.21.1089.1089

Published: 2010

NARROW

Comparison of Cost-Effectiveness of Anticoagulation with Dabigatran, Rivaroxaban and Apixaban in Patients with Non-Valvular Atrial Fibrillation Across Countries

Cluster Analysis Followed by Network Meta-Analysis to Compare Efficacy and Safety of Dabigatran, Rivaroxaban and Apixaban After Elective Total Knee and Hip Replacement Surgery

Indirect Comparisons of the New Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation

Bleeding Intensity Following Tooth Extraction Is Moderated by Anxiety Independently of Treatment with anticoagulants– Development of an Internet Based Questionnaire Across Countries

The Point of Care Monitor Coagucheck-XS Displays the Lowest Coefficient of Variation for Determination of Rivaroxaban Compared to Prothrombin Time and Chromogenic Assays,

Which Patients Would Be Willing to Change Anticoagulation From Vitamin-K Antagonists to a New Oral Anticoagulant?

Determination of the International Sensitivity Index for Rivaroxaban Using the WHO RBT/90 Thromboplastin as a Calibrant for Other Thromboplastin Reagents.

Email alerts

ASH Publications

American Society of Hematology

Comparison of Cost-Effectiveness of Anticoagulation with Dabigatran, Rivaroxaban and Apixaban in Patients with Non-Valvular Atrial Fibrillation Across Countries

Cluster Analysis Followed by Network Meta-Analysis to Compare Efficacy and Safety of Dabigatran, Rivaroxaban and Apixaban After Elective Total Knee and Hip Replacement Surgery

Indirect Comparisons of the New Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation

Bleeding Intensity Following Tooth Extraction Is Moderated by Anxiety Independently of Treatment with anticoagulants– Development of an Internet Based Questionnaire Across Countries

The Point of Care Monitor Coagucheck-XS Displays the Lowest Coefficient of Variation for Determination of Rivaroxaban Compared to Prothrombin Time and Chromogenic Assays,

Which Patients Would Be Willing to Change Anticoagulation From Vitamin-K Antagonists to a New Oral Anticoagulant?

Determination of the International Sensitivity Index for Rivaroxaban Using the WHO RBT/90 Thromboplastin as a Calibrant for Other Thromboplastin Reagents.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only